Advanced search
Publication Cover
Molecular and Cellular Biology Volume 19, 1999 - Issue 2
Submit an article Journal homepage
57
Views
485
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

Miranda Thomas1 International Centre for Genetic Engineering and Biotechnology, I-34012Trieste, Italy
,
Ann Kalita2 Institute of Parasitology
,
Sylvie Labrecque2 Institute of Parasitology
,
David Pim1 International Centre for Genetic Engineering and Biotechnology, I-34012Trieste, Italy
,
Lawrence Banks1 International Centre for Genetic Engineering and Biotechnology, I-34012Trieste, ItalyCorrespondence[email protected]
&
Greg Matlashewski2 Institute of Parasitology;3 McGill Cancer Center, McGill University, Montreal, CanadaCorrespondence[email protected]
Pages 1092-1100 | Received 14 May 1998, Accepted 29 Oct 1998, Published online: 28 Mar 2023

Citations (485)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (20)

Raima Das, Sharbadeb Kundu, Shaheen Laskar, Yashmin Choudhury & Sankar Kumar Ghosh. (2023) In silico assessment of DNA damage response gene variants associated with head and neck cancer. Journal of Biomolecular Structure and Dynamics 41:6, pages 2090-2107.
Read now
Mohammad Jamshidi, Somayeh Mohammadi Pour & Mohammad-Reza Mahmoudian-Sani. (2020) Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review. Pharmacogenomics and Personalized Medicine 13, pages 167-180.
Read now
Wen Fu, Zhen-Jian Zhuo, Wei Jia, Jinhong Zhu, Shi-Bo Zhu, Ze-Feng Lin, Feng-Hua Wang, Huimin Xia, Jing He & Guo-Chang Liu. (2017) Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population. OncoTargets and Therapy 10, pages 1149-1154.
Read now
Michele Salemi, Concetta Barone, Maria Grazia Salluzzo, Mariaconcetta Giambirtone, Francesco Scillato, Rosanna Galati Rando, Carmelo Romano, Maria Concetta Morale, Federico Ridolfo & Corrado Romano. (2017) A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers. The Journal of Maternal-Fetal & Neonatal Medicine 30:22, pages 2752-2754.
Read now
Che-Pei Kung, Qin Liu & Maureen E. Murphy. (2017) The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation. Cancer Biology & Therapy 18:7, pages 484-491.
Read now
Süleyman Bayram, Eyyüp Rencüzoğulları, Abdullah Muttalip Almas & Ahmet Genç. (2016) Effect of p53 Arg72Pro polymorphism on the induction of micronucleus by aflatoxin B1 in in vitro in human blood lymphocytes. Drug and Chemical Toxicology 39:3, pages 331-337.
Read now
Radoslava Vazharova & Ivo Kremensky. (2016) Individual capacity for DNA repair and maintenance of genomic integrity: a fertile ground for studies in the field of assisted reproduction. Biotechnology & Biotechnological Equipment 30:3, pages 419-433.
Read now
Ying Chan, Hongguo Jiang, Lan Ma, Jinbao Chen, Dongya Li, Yushi Meng, Ying Luo & Wenru Tang. (2015) No association of TP53 codon 72 SNP with male infertility: a study in a Chinese population and a meta-analysis. Systems Biology in Reproductive Medicine 61:4, pages 222-227.
Read now
Gwan Gyu Song & Young Ho Lee. (2014) A Meta-analysis of the Association between p53 Codon 72 Polymorphism and Susceptibility to Endometriosis. Immunological Investigations 43:6, pages 595-605.
Read now
Qi Jin, Binbin Wang, Jing Wang, Tao Liu, Xiaoying Yu, Chao Jia, Xiang Fang, Yifeng Peng & Xu Ma. (2013) Association between TP53 gene Arg72Pro polymorphism and idiopathic infertility in southeast Chinese Han males. Systems Biology in Reproductive Medicine 59:6, pages 342-346.
Read now
Rumena Petkova, Pavlina Chelenkova, Husein Yemendzhiev, Iliya Tsekov, Stoyan Chakarov & Zlatko Kalvatchev. (2013) HPV Has Left the Building—the Absence of Detectable HPV DNA and the Presence of R Allele/S for the P72R Polymorphism in the TP53 Gene May Call for More Aggressive Therapeutic Approach in HPV-Associated Tumours. Biotechnology & Biotechnological Equipment 27:6, pages 4217-4221.
Read now
Rumena Petkova, Pavlina Chelenkova, Elena Georgieva & Stoian Chakarov. (2013) What's Your Poison? Impact of Individual Repair Capacity on the Outcomes of Genotoxic Therapies in Cancer. Part I—Role of Individual Repair Capacity in the Constitution of Risk for Late-Onset Multifactorial Disease. Biotechnology & Biotechnological Equipment 27:6, pages 4208-4216.
Read now
Amanda K. Frank, Julia I-Ju Leu, Yan Zhou, Karthik Devarajan, Tatiana Nedelko, Andres Klein-Szanto, Monica Hollstein & Maureen E. Murphy. (2011) The Codon 72 Polymorphism of p53 Regulates Interaction with NF-κB and Transactivation of Genes Involved in Immunity and Inflammation. Molecular and Cellular Biology 31:6, pages 1201-1213.
Read now
Michelle AT Hildebrandt, Jian Gu & Xifeng Wu. (2009) Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opinion on Drug Metabolism & Toxicology 5:7, pages 745-755.
Read now
FARIDE. AHMED. (2006) Gene-Gene, Gene-Environment & Multiple Interactions in Colorectal Cancer. Journal of Environmental Science and Health, Part C 24:1, pages 1-101.
Read now
S. Salvioli, F. Olivieri, F. Marchegiani, M. Cardelli, A. Santoro, E. Bellavista, M. Mishto, L. Invidia, M. Capri, S. Valensin, F. Sevini, E. Cevenini, L. Celani, F. Lescai, E. Gonos, C. Caruso, G. Paolisso, G. De Benedictis, D. Monti & C. Franceschi. (2006) Genes, ageing and longevity in humans: Problems, advantages and perspectives. Free Radical Research 40:12, pages 1303-1323.
Read now
Guillermo Ignacio Pérez-pérez, Francisco Javier Bosques-padilla, Maria Luisa Crosatti, Rolando Tijerina-menchaca & Elvira Garza-gonzález. (2005) Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scandinavian Journal of Gastroenterology 40:1, pages 56-60.
Read now
Anirban Ghosh, Deborah Stewart & Greg Matlashewski. (2004) Regulation of Human p53 Activity and Cell Localization by Alternative Splicing. Molecular and Cellular Biology 24:18, pages 7987-7997.
Read now
L. Gaspari, P. Pedotti, M. Bonafè, C. Franceschi, D. Marinelli, D. Mari, S. Garte & E. Taioli. (2003) Metabolic gene polymorphisms and p53 mutations in healthy centenarians and younger controls. Biomarkers 8:6, pages 522-528.
Read now
Thomas Tan & Gilbert Chu. (2002) p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice. Molecular and Cellular Biology 22:10, pages 3247-3254.
Read now

Articles from other publishers (465)

Sabrina da Silva Santos, Rafaela Soares Senra da Costa, Lilian Freire Diniz, Rafaela Matos Ferreira, Guillermo Patricio Ortega Jácome & Rosalina Jorge Koifman. (2023) TP53 Arg72Pro Genetic Polymorphism and Young Women with Breast Cancer: Case-Control Study in Brazil. Revista Brasileira de Cancerologia 69:2.
Crossref
Ghazaleh Biglari-Zadeh, Saman Sargazi, Malihe Mohammadi, Marzieh Ghasemi, Mahdi Majidpour, Ramin Saravani & Shekoufeh Mirinejad. (2023) Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case–Control Study and In Silico Analyses. Biochemical Genetics.
Crossref
Shiori Nakano, Taiki Yamaji, Ryoko Katagiri, Norie Sawada, Manami Inoue, Shoichiro Tsugane & Motoki Iwasaki. (2022) p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study . Cancer Science 113:12, pages 4385-4393.
Crossref
Mohammad Salman Akhtar & Raed A. Alharbi. (2022) Genetic association of TP53 Pro72Arg polymorphism (rs1042522) in Leukemia: An updated meta-analysis of 10 case-control studies. Human Gene 34, pages 201130.
Crossref
Manisha R. Patil & Anand Bihari. (2022) A comprehensive study of p53 protein. Journal of Cellular Biochemistry 123:12, pages 1891-1937.
Crossref
Yali Su, Yingying Sai, Linfeng Zhou, Zeliang Liu, Panyan Du, Jinghua Wu & Jinghua Zhang. (2022) Current insights into the regulation of programmed cell death by TP53 mutation in cancer. Frontiers in Oncology 12.
Crossref
Kubra Acikalin Coskun, Merve Tutar, Mervenur Al, Asiye Gok Yurttas, Elif Cansu Abay, Nazlican Yurekli, Bercem Yeman Kiyak, Kezban Ucar Cifci & Yusuf Tutar. 2022. p53 - A Guardian of the Genome and Beyond. p53 - A Guardian of the Genome and Beyond.
Meijia Yu, Qin Zhang & Xia Zhao. (2022) Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review. Frontiers in Oncology 12.
Crossref
Matteo Floris, Giovanna Pira, Paolo Castiglia, Maria Idda, Maristella Steri, Maria De Miglio, Andrea Piana, Andrea Cossu, Antonio Azara, Caterina Arru, Giovanna Deiana, Carlo Putzu, Valeria Sanna, Ciriaco Carru, Antonello Serra, Marco Bisail & Maria Muroni. (2022) Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53 , MDM2 and ATM genes in Sardinian women . Oncology Letters 24:4.
Crossref
Golap Babu, Shad Bin Islam & Md. Asaduzzaman Khan. (2022) A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh. Molecular Biology Reports 49:7, pages 6725-6739.
Crossref
A.H. AlBosale & E. V. Mashkina. (2022) Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus. Vavilov Journal of Genetics and Breeding 26:1, pages 59-64.
Crossref
Abbas Hadi Albosale, Olga Andreevna Garbuzova, Konstantin Alekseevich Kovalenko & Elena Vladimirovna Mashkina. (2022) Polymorphism of TP53 gene and the risk of high human papillomavirus load in cervical epithelial cells. Gene Reports 26, pages 101456.
Crossref
Rabeya Akter, Md. Siddiqul Islam, Md. Safiqul Islam, Md. Abdul Aziz, Md. Saddam Hussain, Md. Shalahuddin Millat, Mohammad Sarowar Uddin & Mohammad Safiqul Islam. (2021) A case-control study investigating the association of TP53 rs1042522 and CDH1 rs16260 polymorphisms with prostate cancer risk. Meta Gene 30, pages 100962.
Crossref
Hamida Ali, Muhammad Naeem, Naheed Sajjad, Gul Naz, Abdul Samad, Hafiz Khush Naseeb & Nabeela Tariq. (2021) PCR-RFLP genotyping analysis of TP53 Arg72Pro polymorphism and susceptibility to esophageal cancer in Pakistani population. Gene Reports 25, pages 101406.
Crossref
Luca Lo Piccolo, Salinee Jantrapirom, Sutpirat Moonmuang, Pimpisa Teeyakasem, Arnat Pasena, Pathacha Suksakit, Pimlak Charoenkwan, Dumnoensun Pruksakorn & Nut Koonrungsesomboon. (2021) In search of TP53 mutational hot spots for Li‐Fraumeni syndrome in Asian populations . Tropical Medicine & International Health 26:11, pages 1401-1410.
Crossref
Bu-Yeo Kim, Seo-Young Lee & Sun-Ku Chung. (2021) Differential Transcriptional Regulation of Polymorphic p53 Codon 72 in Metabolic Pathways. International Journal of Molecular Sciences 22:19, pages 10793.
Crossref
Cristabelle De Souza, Jill Madden, Devin C Koestler, Dennis Minn, Dennis J Montoya, Kay Minn, Alan G Raetz, Zheng Zhu, Wen-Wu Xiao, Neeki Tahmassebi, Harikumara Reddy, Nina Nelson, Anthony N Karnezis & Jeremy Chien. (2021) Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer . JNCI: Journal of the National Cancer Institute 113:9, pages 1246-1257.
Crossref
Justina Bekampytė, Agnė Bartnykaitė, Aistė Savukaitytė, Rasa Ugenskienė, Erika Korobeinikova, Jurgita Gudaitienė & Elona Juozaitytė. (2021) The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis. Diagnostics 11:8, pages 1419.
Crossref
Bartosz Słomiński, Maria Skrzypkowska, Monika Ryba-Stanisławowska, Małgorzata Myśliwiec & Piotr Trzonkowski. (2021) Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes. Journal of Molecular Medicine 99:5, pages 675-683.
Crossref
Sanjana Balachandra, Samuel B. Kusin, Rebecca Lee, James‐Michael Blackwell, Jasmin A. Tiro, Lindsay G. Cowell, Cheng‐Ming Chiang, Shwu‐Yuan Wu, Sanskriti Varma, Erika L. Rivera, Helen G. Mayo, Lianghao Ding, Baran D. Sumer, Jayanthi S. Lea, Aditya Bagrodia, Linda M. Farkas, Richard Wang, Carole Fakhry, Kristina R. Dahlstrom, Erich M. Sturgis & Andrew T. Day. (2020) Blood‐based biomarkers of human papillomavirus–associated cancers: A systematic review and meta‐analysis. Cancer 127:6, pages 850-864.
Crossref
Angeles Almeida, Irene Sánchez‐Morán & Cristina Rodríguez. (2021) Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke. IUBMB Life 73:3, pages 582-591.
Crossref
Varvara I. Minina, Yulia A. Nelyubova, Anastaiya O. Sokolova, Yana A. Savchenko, Anastaiya V. Ryzhkova, Olga A. Soboleva, Evgeniya A. Astaf’eva & Andrey N. Glushkov. (2021) Polymorphism of TGF-β1, TР53, CHEK2, ATM genes аnd chromosomal aberrations in workers at coal thermal electric power station. Hygiene and sanitation 100:1, pages 42-48.
Crossref
Mujeeb Zafar Banday, Aga Syed Sameer & Saniya Nissar. 2021. Genetic Polymorphism and cancer susceptibility. Genetic Polymorphism and cancer susceptibility 119 164 .
Anurag Mehta, Smreti Vasudevan, Sanjeev Kumar Sharma, Manoj Panigrahi, Moushumi Suryavanshi, Mumtaz Saifi & Ullas Batra. (2020) Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape. Applied Cancer Research 40:1.
Crossref
Juan CaoZhiqiang ChenChaoyong TianJia YuHongfei ZhangJingwen YangWenjun Yang. (2020) A Shared Susceptibility Locus in the p53 Gene for both Gastric and Esophageal Cancers in a Northwestern Chinese Population . Genetic Testing and Molecular Biomarkers 24:12, pages 804-811.
Crossref
Cristabelle De Souza, Jill A. Madden, Dennis Minn, Vigneshwari Easwar Kumar, Dennis J. Montoya, Roshni Nambiar, Zheng Zhu, Wen-Wu Xiao, Neeki Tahmassebi, Harikumara Kathi, Nina Nelson, Anthony N. Karnezis & Jeremy Chien. (2020) The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression. International Journal of Molecular Sciences 21:21, pages 8025.
Crossref
Ramona A. Eiholzer, Sunali Mehta, Marina Kazantseva, Catherine J. Drummond, Cushla McKinney, Katie Young, David Slater, Brianna C. Morten, Kelly A. Avery-Kiejda, Annette Lasham, Nicholas Fleming, Helen R. Morrin, Karen Reader, Janice A. Royds, Michael Landmann, Simone Petrich, Roger Reddel, Lily Huschtscha, Ahmad Taha, Noelyn A. Hung, Tania L. Slatter & Antony W. Braithwaite. (2020) Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk. Cancers 12:9, pages 2472.
Crossref
Susanna Croci, Miriam Lucia Carriero, Katia Capitani, Sergio Daga, Francesco Donati, Elisa Frullanti, Vittoria Lamacchia, Rossella Tita, Annarita Giliberti, Floriana Valentino, Elisa Benetti, Annalisa Ciabattini, Simone Furini, Caterina Lo Rizzo, Anna Maria Pinto, Silvestro Giovanni Conticello, Alessandra Renieri & Ilaria Meloni. (2020) High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot. European Journal of Human Genetics 28:9, pages 1231-1242.
Crossref
Michele Salemi, Maria Grazia Salluzzo, Concetta Barone & Corrado Romano. (2020) Study of the MDM2 -410T-G polymorphism (rs2279744) by pyrosequencing in mothers of Down Syndrome subjects. Human Cell 33:3, pages 476-478.
Crossref
Yuan Fang, Xuemei Wu, Lin Li, Jinhong Zhu, Haiyan Wu, Haixia Zhou, Jing He & Yizhen Wang. (2020) TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case–control study . Bioscience Reports 40:5.
Crossref
Paula Escalante, Tamara Barría, Miguel Cancino, Maritza Rahal, Leslie Cerpa, Christopher Sandoval, Sebastian Molina-Mellico, Marcelo Suárez, Matias Martínez, Dante Daniel Cáceres, Luis Abel Quiñones & Nelson Miguel Varela. (2020) Genetic polymorphisms as non-modifiable susceptibility factors to laryngeal cancer. Bioscience Reports 40:5.
Crossref
Emmanuel Kwateng Drokow, Yuqing Chen, Hafiz Abdul Waqas Ahmed, Timothy Bonney Oppong, Gloria Selorm Akpabla, Yanru Pei, Maame Awoyoe Kumah, Enyonam Adjoa Neku & Kai Sun. (2020) The relationship between leukemia and TP53 gene codon Arg72Pro polymorphism: analysis in a multi-ethnic population . Future Oncology 16:14, pages 923-937.
Crossref
Sergio Daga, Francesco Donati, Katia Capitani, Susanna Croci, Rossella Tita, Annarita Giliberti, Floriana Valentino, Elisa Benetti, Chiara Fallerini, Francesca Niccheri, Margherita Baldassarri, Maria Antonietta Mencarelli, Elisa Frullanti, Simone Furini, Silvestro Giovanni Conticello, Alessandra Renieri & Anna Maria Pinto. (2019) New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells. European Journal of Human Genetics 28:4, pages 480-490.
Crossref
Brent A. Orr, Michael R. Clay, Emilia M. Pinto & Chimene Kesserwan. (2019) An update on the central nervous system manifestations of Li–Fraumeni syndrome. Acta Neuropathologica 139:4, pages 669-687.
Crossref
Antonella Tramutola, Susanna Falcucci, Umberto Brocco, Francesca Triani, Chiara Lanzillotta, Michele Donati, Chiara Panetta, Fabiola Luzi, Federica Iavarone, Federica Vincenzoni, Massimo Castagnola, Marzia Perluigi, Fabio Di Domenico & Federico De Marco. (2020) Protein Oxidative Damage in UV-Related Skin Cancer and Dysplastic Lesions Contributes to Neoplastic Promotion and Progression. Cancers 12:1, pages 110.
Crossref
Yukimi Ohmori, Takashi Nomura, Norimasa Fukushima, Fumiaki Takahashi, Takeshi Iwaya, Keisuke Koeda & Satoshi S. Nishizuka. (2019) Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms . Journal of Surgical Oncology 120:7, pages 1154-1161.
Crossref
Andrzej Dmytrzak, Agnieszka Boroń, Beata Łoniewska, Klaudyna Lewandowska, Iwona Gorący, Mariusz Kaczmarczyk & Andrzej Ciechanowicz. (2019) Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians . Dermatology Research and Practice 2019, pages 1-5.
Crossref
Le Li, Jinhong Zhu, Tongyi Lu, Wei Liu, Jue Tang, Jiao Zhang, Yizhen Wang, Yong Li, Suhong Li, Haixia Zhou, Huimin Xia, Jing He & Jiwen Cheng. (2019) Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers. Translational Oncology 12:10, pages 1282-1288.
Crossref
S. N. Shilov, A. T. Teplyakov, A. A. Popova, E. N. Berezikova, M. N. Neupokoeva, E. V. Grakova, A. M. Valeeva & Sh. M. Tuleutaev. (2019) Prognostic role of p53 gene polymorphism in risk assessment of anthracycline-induced cardiotoxicity. Kardiologiia 59:7S, pages 15-22.
Crossref
Takashi Kawahara, Takahiro Kojima, Shuya Kandori, Masahiro Kurobe, Takayuki Yoshino, Tomokazu Kimura, Yoshiyuki Nagumo, Ryutaro Ishituka, Koji Mitsuzuka, Shintaro Narita, Takashi Kobayashi, Yoshiyuki Matsui, Osamu Ogawa, Mikio Sugimoto, Jun Miyazaki & Hiroyuki Nishiyama. (2019) TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer. PLOS ONE 14:8, pages e0220173.
Crossref
Jialei Yang, Xulong Wu, Jiao Huang, Zhaoxia Chen, Guifeng Huang, Xiaojing Guo, Lulu Zhu & Li Su. (2019) TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population. Journal of Molecular Neuroscience 68:4, pages 679-687.
Crossref
Tsz On Lai, Siaw Shi Boon, Priscilla TY Law, Zigui Chen, Miranda Thomas, Lawrence Banks & Paul KS Chan. (2019) Oncogenicitiy Comparison of Human Papillomavirus Type 52 E6 Variants. Journal of General Virology 100:3, pages 484-496.
Crossref
Grecia Uscanga‑Perales, Sandra Santuario‑Facio, Celia Sanchez‑Dominguez, Servando Cardona‑Huerta, Gerardo Mu�oz‑Maldonado, Pablo Ruiz‑Flores, Jose Barcenas‑Walls, Luis Osuna‑Rosales, Augusto Rojas‑Martinez, Juan Gonzalez‑Guerrero, Javier Valero‑Gomez, Gabriela Gomez‑Macias, Alvaro Barbosa‑Quintana, Oralia Barboza‑Quintana, Raquel Garza‑Guajardo & Rocio Ortiz‑Lopez. (2019) Genetic alterations of triple negative breast cancer (TNBC) in women from Northeastern Mexico. Oncology Letters.
Crossref
Maria Cabezas, Lydia García-Quevedo, Cintia Alonso, Marta Manubens, Yolanda Álvarez, Joan Francesc Barquinero, Santiago Ramón y Cajal, Margarita Ortega, Adoración Blanco, María Rosa Caballín & Gemma Armengol. (2019) Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms. Scientific Reports 9:1.
Crossref
Missiani Ochwoto, Colins O. Oduma, Julius Oyugi, Dufton Mwaengo, Bartholomew N. Ondigo, James H. Kimotho, Alex K. Maiyo, Ruth M. Nyangacha, Gladys Chesumbai & Elijah Songok. (2019) Human TP53 gene polymorphisms among patients with hepatocellular carcinoma and chronic hepatitis B in Kenya. F1000Research 8, pages 1364.
Crossref
Tatiane K. Furuya, Carlos E. Jacob, Michele T.P. Tomitão, Lizeth C.C. Camacho, Marcus F.K.P. Ramos, José Eluf-Neto, Venâncio A.F. Alves, Bruno Zilberstein, Ivan Cecconello, Ulysses Ribeiro Jr.Roger Chammas. (2018) Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer. Genes 9:12, pages 631.
Crossref
Stephanie Antoun, David Atallah, Roula Tahtouh, Nada Alaaeddine, Malak Moubarak, Abir Khaddage, Eliane Nasr Ayoub, George Chahine & George Hilal. (2018) Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles. Cancer Cell International 18:1.
Crossref
Mojgan Mokhtari, Sepideh Zakerian, Farzaneh Farajian-Mashhadi & Saeedeh Salimi. (2018) Association of PvuII T> C and XbaI A> G Polymorphisms of Estrogen Receptor α Gene with Uterine Leiomyoma: A Case-Control Study. Gene, Cell and Tissue In Press:In Press.
Crossref
Rym Abderrahmane, Khedidja Benseddik, Lotfi Louhibi, Fatima Zohra Moghtit, Amina Boubekeur, Abdellah Boudjema, Fouzia Benrrahal & Nadhira Saidi-Mehtar. (2018) Basal Cell Carcinoma Risk and TP53 Arg72Pro Polymorphism: An Algerian Population Study. International Journal of Cancer Management 11:4.
Crossref
Ahd Oulad Lahsen, Hanâ Baba, Rajaa Bensghir, Naouar Fayssel, Mustapha Sodqi, Latifa Marih, Sellama Nadifi, Lahcen Wakrim, Kamal Marhoum El Filali & Sayeh Ezzikouri. (2017) TP53 R72P Polymorphism and Susceptibility to Human Papillomavirus Infection Among Women With Human Immunodeficiency Virus in Morocco: A Case-control Study. Journal of Cancer Prevention 22:4, pages 248-253.
Crossref
Anqi Zhang, Ting-Yan Shi, Yuan Zhao, Junmiao Xiang, Danyang Yu, Zongwen Liang, Chaoyi Xu, Qiong Zhang, Yue Hu, Danhan Wang, Jing He & Ping Duan. (2017) No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects . Oncotarget 8:68, pages 112761-112769.
Crossref
Yalu Liu, Xiaogan Wang, Ning Ding, Lan Mi, Lingyan Ping, Xuan Jin, Jiao Li, Yan Xie, Zhitao Ying, Weiping Liu, Chen Zhang, Lijuan Deng, Yuqin Song & Jun Zhu. (2017) TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP. BMC Cancer 17:1.
Crossref
Shiirevnyamba Avirmed, Bo-Shen Wang, Baasansuren Selenge, Amarsaikhan Sanjaajamts, Batmunkh Ganbat, Ulziisaikhan Erdenebileg, Myagmarsuren Purevsuren, Sarantsetseg Jigjidsuren, Munkhbat Batmunkh & Yi-Jang Lee. (2017) Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population. Molecular and Clinical Oncology 7:3, pages 412-420.
Crossref
Ming Li, Dapeng Wang, Yumin Wang, Guili Sun, Wanli Song, Bin Zhang & Burenbatu Borjigin. (2017) Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia. Oncology Letters 14:2, pages 1484-1490.
Crossref
Amir Hossain, Gazi Md. Monjur Murshid, Md. Nazmul Hasan Zilani, Fahrima Islam, Razia Sultana, Tamanna Sultana, Md. Golam Hossain & Md. Mustafizur Rahman. (2016) TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population. Breast Cancer 24:4, pages 571-578.
Crossref
Khaldon Bodoor, Abdulhameed Al-Ghabkari, Ismail Matalka, Yazan Haddad, Asem Alkhateeb, Saied Jaradat, Ziad W Jaradat, Mohammed Al-Ghazo, Aya Abu-sheikha, Sara Abu Jalboush & Yousef Jarun. (2017) Assessment of p53 mutations, expression and prognosis in bladder cancer patients from Jordan: Identification of novel deletion mutations in the DNA-binding domain. Meta Gene 12, pages 33-42.
Crossref
Song Fan, Zong‐Yao Hao, Meng Zhang & Chao‐Zhao Liang. (2017) Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta‐analysis . Chronic Diseases and Translational Medicine 3:2, pages 95-104.
Crossref
Patricia Carrera-Lasfuentes, Angel Lanas, Luis Bujanda, Mark Strunk, Enrique Quintero, Santos Santolaria, Rafael Benito, Federico Sopeña, Elena Piazuelo, Concha Thomson, Angeles Pérez-Aisa, David Nicolás-Pérez, Elizabeth Hijona, Jesús Espinel, Rafael Campo, Marisa Manzano, Fernando Geijo, María Pellise, Manuel Zaballa, Ferrán González-Huix, Jorge Espinós, Llúcia Titó, Luis Barranco, Mauro D'Amato & María Asunción García-González. (2017) Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype. Oncotarget 8:22, pages 35848-35862.
Crossref
Ana Carolina Silva Chuery, Ismael Dale Cotrim Guerreiro da Silva, Julisa Chamorro Lascasas Ribalta & Neila Maria de Góis Speck. (2017) Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression. The Brazilian Journal of Infectious Diseases 21:3, pages 248-254.
Crossref
D. Borchiellini, M.C. Etienne-Grimaldi, R.J. Bensadoun, K. Benezery, O. Dassonville, G. Poissonnet, L. Llorca, N. Ebran, P. Formento, Y. Château, J. Thariat & G. Milano. (2017) Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer. Oral Oncology 67, pages 70-76.
Crossref
Alvida Qvick, Bengt Sorbe, Gisela Helenius, Mats G. Karlsson & Gabriella Lillsunde Larsson. (2017) Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?. Medical Oncology 34:3.
Crossref
Xin Tian, Shundong Dai, Jing Sun, Shenyi Jiang & Youhong Jiang. (2016) The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies . Oncotarget 8:1, pages 1156-1165.
Crossref
Volkan KARACAOĞLAN, Ahmet Oğuz ADA, Serdar BİLGEN, Guzide Tuğba ÇETİNKAYA, Emre SOYDAŞ, Celalettin Semih KUNAK, Sibel Meryem ALPAR, Meral GÜLHAN & Mümtaz İŞCAN. (2017) Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients. TURKISH JOURNAL OF MEDICAL SCIENCES 47, pages 554-562.
Crossref
Abozar Soleimani, Yousef Rahmani, Negin Farshchian, Ali Delpisheh, Kivan Khassi, Afshar Shahmohammadi & Nasrin Amirifard. (2016) The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis. Journal of Cancer Prevention 21:4, pages 288-293.
Crossref
Ahmet Oguz Ada, Serdar Bilgen, Volkan Karacaoglan, Celalettin Semih Kunak, Emre Soydas, Sibel Alpar, Meral Gulhan & Mumtaz Iscan. (2016) Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer. Archives of Industrial Hygiene and Toxicology 67:4, pages 311-316.
Crossref
Sajidah Khan, Alisa Phulukdaree, Prithiksha Ramkaran, Devapregasan Moodley & Anil A. Chuturgoon. (2016) The Arg72 variant of the p53 functional polymorphism (rs1042522) is associated with coronary artery disease in young South Africans of Indian ancestry. Gene 593:2, pages 261-264.
Crossref
Jineun Kim, Seoyun Yum, Changwon Kang & Suk-Jo Kang. (2016) Gene-gene interactions in gastrointestinal cancer susceptibility. Oncotarget 7:41, pages 67612-67625.
Crossref
Silvia Mahmood, Andrea Evinová, Mária Škereňová, Igor Ondrejka & Ján Lehotský. (2016) Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population. Central European Journal of Public Health 24:3, pages 223-230.
Crossref
Xinzi Lin, Dabiao Hou, Chenlingzi Huang & Xin Luo. (2016) The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis. Archives of Gynecology and Obstetrics 294:2, pages 353-359.
Crossref
Kristy A. Warner, Felipe Nör, Gerson A. Acasigua, Manoela D. Martins, Zhaocheng Zhang, Scott A. McLean, Matthew E. Spector, Douglas B. Chepeha, Joseph Helman, Michael J. Wick, Christopher A. Moskaluk, Rogerio M. Castilho, Alexander T. Pearson, Shaomeng Wang & Jacques E. Nör. (2016) Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma. Clinical Cancer Research 22:14, pages 3550-3559.
Crossref
Natalia Weich, Cristian Ferri, Beatriz Moiraghi, Raquel Bengió, Isabel Giere, Carolina Pavlovsky, Irene Larripa & Ariela Fundia. (2016) TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome. Blood Cells, Molecules, and Diseases 59, pages 129-133.
Crossref
P. Yadav, M. Masroor, K. Tanwer, R. Mir, J. Javid, I. Ahmad, M. Zuberi, R. C. M. Kaza, S. K. Jain, N. Khurana, P. C. Ray & A. Saxena. (2015) Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clinical and Translational Oncology 18:7, pages 728-734.
Crossref
Li Xue, Xiujuan Han, Rongrong Liu, Ziming Wang, Hecheng Li, Qi Chen, Peng Zhang, Zhenlong Wang & Tie Chong. (2015) MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer. Oncotarget 7:22, pages 31825-31831.
Crossref
Jungnam Joo, Kyong-Ah Yoon, Tomonori Hayashi, Sun-Young Kong, Hye-Jin Shin, Boram Park, Young Min Kim, Sang-Hyun Hwang, Jeongseon Kim, Aesun Shin & Joo-Young Kim. (2016) Nucleotide Excision Repair Gene <i>ERCC2</i> and <i>ERCC5</i> Variants Increase Risk of Uterine Cervical Cancer. Cancer Research and Treatment 48:2, pages 708-714.
Crossref
Lewis Reynolds. (2016) The success of stem cell transplantations and the potential post-transplantation complications may be dependent, among other factors, on the capacity of the recipient and the transplanted cells to repair DNA damage. BioDiscovery 19, pages e9076.
Crossref
Che-Pei Kung, Julia I-Ju Leu, Subhasree Basu, Sakina Khaku, Frederick Anokye-Danso, Qin Liu, Donna L. George, Rexford S. Ahima & Maureen E. Murphy. (2016) The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Reports 14:10, pages 2413-2425.
Crossref
Moqin Qiu, Yingchun Liu, Xiangyuan Yu, Linyuan Qin, Chunhua Bei, Xiaoyun Zeng, Xiaoqiang Qiu, Bo Tang, Songqing He & Hongping Yu. (2015) Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma. Tumor Biology 37:3, pages 3863-3870.
Crossref
Alexandra S. Shadrina, Natalia A. Ermolenko, Uljana A. Boyarskikh, Tatiana V. Sinkina, Alexandr F. Lazarev, Valentina D. Petrova & Maxim L. Filipenko. (2014) Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case–control study. Clinical and Experimental Medicine 16:1, pages 21-28.
Crossref
S. Dholariya, R. Mir, M. Zuberi, P. Yadav, G. Gandhi, N. Khurana, A. Saxena & P. C. Ray. (2015) Potential impact of (rs 4645878) BAX promoter −248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients. Clinical and Translational Oncology 18:1, pages 73-81.
Crossref
Khadija Rebbani, Agnès Marchio, Sayeh Ezzikouri, Rajaa Afifi, Mostafa Kandil, Olfa Bahri, Henda Triki, Abdellah Essaid El Feydi, Anne Dejean, Soumaya Benjelloun & Pascal Pineau. (2015) TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma. Molecular Cancer 14:1.
Crossref
Nikolai V. Litviakov, Maxim B. Freidin, Aleksey E. Sazonov, Maria V. Khalyuzova, Mikhail A. Buldakov, Mikhail S. Karbyshev, Еlena N. Albakh, Daria S. Isubakova, Аleksey A. Gagarin, Gennadiy B. Nekrasov, Elena B. Mironova, Аndrey S. Izosimov, Ravil M. Takhauov & Аndrei B. Karpov. (2015) Different patterns of allelic imbalance in sporadic tumors and tumors associated with long-term exposure to gamma-radiation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 794, pages 8-16.
Crossref
Mizuo Ando, Yuki Saito, Teppei Morikawa, Go Omura, Kenya Kobayashi, Ken Akashi, Masafumi Yoshida, Yasuhiro Ebihara, Chisato Fujimoto, Masashi Fukayama, Tatsuya Yamasoba & Takahiro Asakage. (2015) Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing . Head & Neck 37:12, pages E179-E185.
Crossref
MOHD NIZAM ZAHARY, ABDUL AZIZ AHMAD AIZAT, GURJEET KAUR, LEE YEONG YEH, MAYA MAZUWIN & RAVINDRAN ANKATHIL. (2015) Polymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: Association with colorectal cancer susceptibility risk in a Malaysian population. Oncology Letters 10:5, pages 3216-3222.
Crossref
Kathy L. McGraw, Thomas Cluzeau, David A. Sallman, Ashley A. Basiorka, Brittany A. Irvine, Ling Zhang, P.K. Epling-Burnette, Dana E. Rollison, Mar Mallo, Lubomir Sokol, Francesc Solé, Jaroslaw Maciejewski & Alan F. List. (2015) TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes . Oncotarget 6:33, pages 34437-34445.
Crossref
MONIKA KMEŤOVÁ SIVOŇOVÁ, MARTA VILČKOVÁ, JÁN KLIMENT, SILVIA MAHMOOD, JANA JUREČEKOVÁ, SVETLANA DUŠENKOVÁ, IVETA WACZULÍKOVÁ, PETER SLEZÁK & DUŠAN DOBROTA. (2015) Association of p53 and p21 polymorphisms with prostate cancer. Biomedical Reports 3:5, pages 707-714.
Crossref
Jennilee Davidson, Michael D. Cusimano & William G. Bendena. (2014) Post-Traumatic Brain Injury. The Neuroscientist 21:4, pages 424-441.
Crossref
Annie-Pier Beauregard, Jason Harquail, Grégoire Lassalle-Claux, Mehdi Belbraouet, Jacques Jean-Francois, Mohamed Touaibia & Gilles Robichaud. (2015) CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells. Molecules 20:7, pages 12576-12589.
Crossref
Yulan Yan, Renzheng Wu, Shaojing Li & Jinlong He. (2015) Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case–control studies. European Journal of Obstetrics & Gynecology and Reproductive Biology 189, pages 1-7.
Crossref
Miraj Kobad Chowdhury, Md Moniruzzaman, Abdullah Al Emran, Mohammad Golam Mostafa, Ruhul H Kuddus & M Aftab Uddin. (2015) TP53 Codon 72 Polymorphisms and Lung Cancer Risk in the Bangladeshi Population. Asian Pacific Journal of Cancer Prevention 16:8, pages 3493-3498.
Crossref
Pattamawadee Yanatatsaneejit, Ajaree Boonsrang, Apiwat Mutirangura, Vyomesh Patel & Nakarin Kitkumthorn. (2015) P53 Polymorphism at Codon 72 is Associated with Keratocystic Odontogenic Tumors in the Thai Population. Asian Pacific Journal of Cancer Prevention 16:5, pages 1997-2001.
Crossref
K L McGraw, L M Zhang, D E Rollison, A A Basiorka, W Fulp, B Rawal, A Jerez, D L Billingsley, H-Y Lin, S E Kurtin, S Yoder, Y Zhang, K Guinta, M Mallo, F Solé, M J Calasanz, J Cervera, E Such, T González, T J Nevill, T Haferlach, A E Smith, A Kulasekararaj, G Mufti, A Karsan, J P Maciejewski, L Sokol, P K Epling-Burnette, S Wei & A F List. (2015) The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes. Blood Cancer Journal 5:3, pages e291-e291.
Crossref
Yasuki Hori, Katsuyuki Miyabe, Michihiro Yoshida, Takahiro Nakazawa, Kazuki Hayashi, Itaru Naitoh, Shuya Shimizu, Hiromu Kondo, Yuji Nishi, Shuichiro Umemura, Akihisa Kato, Hirotaka Ohara, Hiroshi Inagaki & Takashi Joh. (2015) Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma. PLOS ONE 10:3, pages e0118829.
Crossref
Farinaz Behfarjam, Jalal Rostamzadeh, Mohammad Ali Zarei & Bahram Nikkhoo. (2015) Association of Two Polymorphic Codons in P53 and ABCC1 Promoter with Prostate Cancer. Iranian Journal of Biotechnology 13:1, pages 49-54.
Crossref
Che-Pei Kung, Sakina Khaku, Matthew Jennis, Yan Zhou & Maureen E. Murphy. (2015) Identification of TRIML2, a Novel p53 Target, that Enhances p53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes. Molecular Cancer Research 13:2, pages 250-262.
Crossref
Natalia Volodko. (2015) TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. World Journal of Gastroenterology 21:36, pages 10358.
Crossref
Meire Luzia Gonçalves, Sarah Moreira Borja, Jacqueline Andréia Bernardes Leão Cordeiro, Vera Aparecida Saddi, Flávio Monteiro Ayres, Cesar Augusto Sam Tiago Vilanova-Costa & Antonio Márcio Teodoro Cordeiro Silva. (2014) Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis. SpringerPlus 3:1.
Crossref
Eduardo AVF Ramalho, João LQ Silva-Filho, Marina FS Cartaxo, Carmelita BL Cavalcanti, Moacyr JBM Rêgo, Maria BM Oliveira & Eduardo IC Beltrão. (2014) Assessment of changes in the brca2 and p53 genes in breast invasive ductal carcinoma in northeast Brazil. Biological Research 47:1.
Crossref
Yanni Xi, Congrong Liu & Xiaoyan Xin. (2014) Association Between a Single Nucleotide Polymorphism in the TP53 Region and Risk of Ovarian Cancer. Cell Biochemistry and Biophysics 70:3, pages 1907-1912.
Crossref
Yi‐Chang Liu, Hui‐Hua Hsiao, Wen‐Chi Yang, Ta‐Chih Liu, Chao‐Sung Chang, Ming‐Yu Yang, Pai‐Mei Lin, Jui‐Feng Hsu, Ching‐Ping Lee & Sheng‐Fung Lin. (2013) MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast‐free survival in chronic phase patients receiving imatinib. Molecular Carcinogenesis 53:12, pages 951-959.
Crossref
Carolina C. Gomes, Thiago Fonseca-Silva, Marina G. Diniz, Lissur A. Orsine & Ricardo S. Gomez. (2014) TP53 single nucleotide polymorphism rs1042522 in salivary gland neoplasms . Head & Neck 36:12, pages 1685-1688.
Crossref
Renu Pandey, Vatsala Misra, Sri Prakash Misra, Manisha Dwivedi & Alok Misra. (2014) Helicobacter pylori Infection and a P53 Codon 72 Single Nucleotide Polymorphism: a Reason for an Unexplained Asian Enigma. Asian Pacific Journal of Cancer Prevention 15:21, pages 9171-9176.
Crossref
Hitendra S. Chand, Gilbert Montano, Xuesong Huang, Scott H. Randell, Yohannes Mebratu, Hans Petersen & Yohannes Tesfaigzi. (2014) A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression. Nature Communications 5:1.
Crossref
Sukhpreet Kaur, Vasudha Sambyal, Kamlesh Guleria, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh, Gursimran Singh & Harpreet Singh. (2014) Analysis of TP53 Polymorphisms in North Indian Sporadic Esophageal Cancer Patients. Asian Pacific Journal of Cancer Prevention 15:19, pages 8413-8422.
Crossref
Steven Habbous, Vincent Pang, Wei Xu, Eitan Amir & Geoffrey Liu. (2014) Human papillomavirus and host genetic polymorphisms in carcinogenesis: A systematic review and meta-analysis. Journal of Clinical Virology 61:2, pages 220-229.
Crossref
Md. Shaki Mostaid, Maizbha Uddin Ahmed, Mohammad Safiqul Islam, Muhammad Shahdaat Bin Sayeed & Abul Hasnat. (2014) Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population. Tumor Biology 35:10, pages 10309-10317.
Crossref
Raju K. Mandal, Suraj S. Yadav & Aditya K. Panda. (2014) No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis. Tumor Biology 35:9, pages 8607-8613.
Crossref
Sarika Sharma, Vasudha Sambyal, Kamlesh Guleria, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh, Darpan Bansal & Arun Gupta. (2014) TP53 Polymorphisms in Sporadic North Indian Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention 15:16, pages 6871-6879.
Crossref
Jayanta Sarkar, Emily Dominguez, Guojun Li, Donna F. Kusewitt & David G. Johnson. (2014) Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility. Molecular Carcinogenesis 53:8, pages 648-658.
Crossref
Charles C. Weige, Marc R. Birtwistle, Himel Mallick, Nengjun Yi, Zuzana Berrong, Emily Cloessner, Keely Duff, Josephine Tidwell, Megan Clendenning, Brent Wilkerson, Christopher Farrell, Fred Bunz, Hao Ji, Michael Shtutman, Kim E. Creek, Carolyn E. Banister & Phillip J. Buckhaults. (2014) Transcriptomes and shRNA Suppressors in a TP53 Allele–Specific Model of Early-Onset Colon Cancer in African Americans . Molecular Cancer Research 12:7, pages 1029-1041.
Crossref
Silvia Mahmood, Monika Sivoňová, Tatiana Matáková, Dusan Dobrota, Ladislava Wsólová, Anton Dzian & Dusan Mištuna. (2014) Association of EGF and p53 gene polymorphisms and colorectal cancer risk in the Slovak population. Open Medicine 9:3, pages 405-416.
Crossref
Monowarul Mobin Siddique, Zhao Yi, Lim Hui Qin, Gita Krishnaswamy & Eng King Tan. (2014) Association study of p53 codon 72 polymorphism in Parkinson's disease. Basal Ganglia 4:2, pages 71-73.
Crossref
Yu Lu, Yanqiong Liu, Jie Zeng, Yu He, Qiliu Peng, Yan Deng, Jian Wang, Li Xie, Taijie Li, Xue Qin & Shan Li. (2014) Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis. Tumor Biology 35:5, pages 3997-4005.
Crossref
Zhengqi Chang & Xiuchun Yu. (2014) Association between p53 codon 72 polymorphism and sarcoma risk among Caucasians. Tumor Biology 35:5, pages 4807-4812.
Crossref
Mohammad Nabavi, Abbas Ghaderi, Mohammad Javad Fattahi, N. Danaie, R. Zangooie & Mohammad Faranoush. (2014) Association between p53 codon 72 polymorphism and systemic lupus erythematosus. Rheumatology 52:2, pages 94-98.
Crossref
Mohammed A. A. Alqumber, Naseem Akhter, Shafiul Haque, Aditya K. Panda & Raju K. Mandal. (2014) Evaluating the Association between p53 Codon 72 Arg>Pro Polymorphism and Risk of Ovary Cancer: A Meta-Analysis. PLoS ONE 9:4, pages e94874.
Crossref
Lizbeth González-Herrera, Patricia Rodríguez-Morales, María del Refugio González-Losa, Gerardo Pérez-Mendoza, Jaqueline Canul-Canché, Iván Rosado-López & Thelma Canto de Cetina. (2014) MTHFR/p53 Polymorphisms as Genetic Factors for Cervical Intraepithelial Neoplasia and Cervical Cancer in HPV-infected Mexican Women . The International Journal of Biological Markers 29:2, pages 142-149.
Crossref
Ting Liu, Zeyuan Lei, ZhengYing Pan, Yu Chen, Xiang Li, TongChun Mao, Qian He & Dongli Fan. (2013) Genetic association between p53 codon 72 polymorphism and risk of cutaneous squamous cell carcinoma. Tumor Biology 35:4, pages 3899-3903.
Crossref
LIGIA PETROLINI DE OLIVEIRA, IGNACIO LÓPEZ, ERIKA MARIA MONTEIRO DOS SANTOS, PAULA TUCCI, MÓNICA MARÍN, FERNANDO AUGUSTO SOARES, BENEDITO MAURO ROSSI & RENATA DE ALMEIDA COUDRY. (2014) Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis. Oncology Reports 31:3, pages 1396-1406.
Crossref
Simon Blechman Zeichner, Sarah Alghamdi, Gina Elhammady, Robert John Poppiti & Amilcar Castellano-Sanchez. (2014) Prognostic Significance of TP53 Mutations and Single Nucleotide Polymorphisms in Acute Myeloid Leukemia: A case Series and Literature Review. Asian Pacific Journal of Cancer Prevention 15:4, pages 1603-1609.
Crossref
Fernando Pires Hartwig, Ludmila Gonçalves Entiauspe, Emily Montosa Nunes, Fernanda Martins Rodrigues, Tiago Collares, Fabiana Kömmling Seixas & Mariângela Freitas da Silveira. (2014) Evidence for an Epistatic Effect between TP53 R72P and MDM2 T309G SNPs in HIV Infection: A Cross-Sectional Study in Women from South Brazil. PLoS ONE 9:2, pages e89489.
Crossref
Erwin Reiling, Ewoud N. Speksnijder, Amanda C. M. Pronk, Sjoerd A. A. van den Berg, Silvia J. W. Neggers, Ilma Rietbroek, Harry van Steeg & Martijn E. T. Dollé. (2014) Human TP53 polymorphism (rs1042522) modelled in mouse does not affect glucose metabolism and body composition. Scientific Reports 4:1.
Crossref
Mridul Malakar, K. Rekha Devi, Rup Kumar Phukan, Tanvir Kaur, Manab Deka, Lalhriat Puia, Lalrinliana Sailo, T. Lalhmangaihi, Debajit Barua, Sanjib Kumar Rajguru, Jagadish Mahanta & Kanwar Narain. (2014) p53 Codon 72 Polymorphism Interactions with Dietary and Tobacco Related Habits and Risk of Stomach Cancer in Mizoram, India. Asian Pacific Journal of Cancer Prevention 15:2, pages 717-723.
Crossref
XIAOXUE XIE, HEKUN JIN, JUN HU, YONG ZENG, JUMEI ZHOU, SHUYU OUYANG, WENJUAN YANG, BINGQIANG HU & HUI WANG. (2014) Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma. Oncology Reports 31:1, pages 223-231.
Crossref
Emad F. Eskander, Ahmed A. Abd-Rabou, Shaymaa M. M. Yahya, Ashraf El Sherbini, Mervat S. Mohamed & Olfat G. Shaker. (2013) “P53 Codon 72 Single Base Substitution in Viral Hepatitis C and Hepatocarcinoma Incidences”. Indian Journal of Clinical Biochemistry 29:1, pages 3-7.
Crossref
Xiang-Hua Ye, Zhi-Bin Bu, Jie Feng, Ling Peng, Xin-Biao Liao, Xin-Li Zhu, Xiao-li Sun, Hao-Gang Yu, Dan-Fang Yan & Sen-Xiang Yan. (2013) Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis. Molecular Biology Reports 41:1, pages 373-385.
Crossref
Xiaoyu Zuo, Shaoqi Rao, An Fan, Meihua Lin, Haoli Li, Xiaolei Zhao & Jiheng Qin. (2013) To Control False Positives in Gene-Gene Interaction Analysis: Two Novel Conditional Entropy-Based Approaches. PLoS ONE 8:12, pages e81984.
Crossref
QI SHI, KANG XIAO, WEI WEI, BAO-YUN ZHANG, CAO CHEN, YIN XU, LI-NA CHEN, YUN-TAO SONG, XIAO MA, NAI-SONG ZHANG & XIAO-PING DONG. (2013) Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients. Oncology Reports 30:6, pages 2811-2819.
Crossref
Xiaoxue Xie, Hui Wang, Hekun Jin, Shuyu Ouyang, Jumei Zhou, Jun Hu, Xuping Xi, Junming Luo, Yingying Zhang & Bingqiang Hu. (2013) Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma. Radiation Oncology 8:1.
Crossref
SHUN MATSUURA, KAZUYA SHINMURA, TAKAHARU KAMO, HISAKI IGARASHI, KYOKO MARUYAMA, MARI TAJIMA, HIROSHI OGAWA, MASAYUKI TANAHASHI, HIROSHI NIWA, KAZUHITO FUNAI, TAKASHI KOHNO, TAKAFUMI SUDA & HARUHIKO SUGIMURA. (2013) CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma. Oncology Reports 30:4, pages 1675-1680.
Crossref
Lanjun ZhaoXilong ZhaoXiaoming WuWenru Tang. (2013) Association of p53 Arg72Pro Polymorphism with Esophageal Cancer: A Meta-Analysis Based on 14 Case-Control Studies . Genetic Testing and Molecular Biomarkers 17:10, pages 721-726.
Crossref
Siyang Wang, Xingang Lan, Sheng Tan, Siwen Wang & Yu Li. (2013) P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis. Tumor Biology 34:5, pages 2511-2520.
Crossref
Yang-Wu Ren, Zhi-Hua Yin, Yan Wan, Peng Guan, Wei Wu, Xue-Lian Li & Bao-Sen Zhou. (2013) P53 Arg72Pro and MDM2 SNP309 Polymorphisms Cooperate to Increase Lung Adenocarcinoma Risk in Chinese Female Non-smokers: A Case Control Study. Asian Pacific Journal of Cancer Prevention 14:9, pages 5415-5420.
Crossref
S.K. Gantsev, V.Y. Gorbunova, G.F. Galikeeva, E.V. Vorobyeva, E.M. Vasilyeva & R.A. Rustamhanov. (2013) Molecular Genetic Study of the Allelic State of the Cell Cycle Genes (TP53, BRCA1) and Features of the Regulation of the Cytokine Cascade in Breast Cancer. Journal of Cancer Research Updates 2:3.
Crossref
Emina Malisic, Radmila Jankovic, Ksenija Brotto & Sinisa Radulovic. (2013) TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women. Archives of Gynecology and Obstetrics 288:3, pages 621-625.
Crossref
Saima Saleem, Abid Azhar, Abdul Hameed, Mansoor Ahmed Khan, Zubair Ahmed Abbasi, Navid Rashid Qureshi & Muhammad Ajmal. (2013) P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan. Oral Oncology 49:8, pages 818-823.
Crossref
Helena S. Thurow, Fernando P. Hartwig, Clarice S. Alho, Deborah S. B. S. Silva, Rafael Roesler, Ana Lucia Abujamra, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Bernardo L. Horta, Odir A. Dellagostin, Tiago Collares & Fabiana K. Seixas. (2013) Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs. Molecular Biology Reports 40:8, pages 4929-4934.
Crossref
Qian Qiao & Weiguo Hu. (2013) The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects. Lung 191:4, pages 369-377.
Crossref
Jialu ChenBo ZhuJingwei ChenYongjian Li. (2013) Genetic Variations in MDM2 and P53 Genes Confer Risk for Adult Acute Lymphoblastic Leukemia in a Chinese Population . DNA and Cell Biology 32:7, pages 414-419.
Crossref
Issa J. Dahabreh, Christopher H. Schmid, Joseph Lau, Vasileia Varvarigou, Samuel Murray & Thomas A. Trikalinos. (2013) Genotype Misclassification in Genetic Association Studies of the rs1042522 TP53 (Arg72Pro) Polymorphism: A Systematic Review of Studies of Breast, Lung, Colorectal, Ovarian, and Endometrial Cancer. American Journal of Epidemiology 177:12, pages 1317-1325.
Crossref
Aga Syed Sameer. (2013) Colorectal cancer: a researcher’s perspective of the molecular angel’s gone eccentric in the Vale of Kashmir. Tumor Biology 34:3, pages 1301-1315.
Crossref
Anna Rita Bonfigli, Cristina Sirolla, Roberto Testa, Michela Cucchi, Liana Spazzafumo, Stefano Salvioli, Antonio Ceriello, Fabiola Olivieri, Roberto Festa, Antonio Domenico Procopio, Gabriele Brandoni, Massimo Boemi, Maurizio Marra & Claudio Franceschi. (2012) The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study. Acta Diabetologica 50:3, pages 429-436.
Crossref
Fang-Ming Chen, Fu Ou-Yang, Sheau-Fang Yang, Eing-Mei Tsai & Ming-Feng Hou. (2013) p53 codon 72 polymorphism in Taiwanese breast cancer patients. The Kaohsiung Journal of Medical Sciences 29:5, pages 259-264.
Crossref
Maral Jamshidi, Marjanka K. Schmidt, Thilo Dörk, Montserrat Garcia-Closas, Tuomas Heikkinen, Sten Cornelissen, Alexandra J. van den Broek, Peter Schürmann, Andreas Meyer, Tjoung-Won Park-Simon, Jonine Figueroa, Mark Sherman, Jolanta Lissowska, Garrett Teoh Hor Keong, Astrid Irwanto, Marko Laakso, Sampsa Hautaniemi, Kristiina Aittomäki, Carl Blomqvist, Jianjun Liu & Heli Nevanlinna. (2013) Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome. International Journal of Cancer 132:9, pages 2044-2055.
Crossref
D. E. Ivanoshchuk, S. V. Mikhailova, I. V. Kulikov, V. N. Maksimov, M. I. Voevoda & A. G. Romashchenko. (2013) CCR5, CCR2, apoE, p53, ITGB3, and HFE gene polymorphism in Western Siberian long livers. Advances in Gerontology 3:2, pages 89-92.
Crossref
Qi Zhang, Ying-Yu Ma, Hui-Ju Wang, Chang-Ming Shao, Jun Zhang & Zai-Yuan Ye. (2013) Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer. Journal of Surgical Oncology 107:4, pages 360-366.
Crossref
A. L. Marshall & D. C. Christiani. (2013) Genetic susceptibility to lung cancer--light at the end of the tunnel?. Carcinogenesis 34:3, pages 487-502.
Crossref
Salvador Pastor-Idoate, Irene Rodriguez-Hernández, Jimena Rojas, Itziar Fernández, María Teresa García-Gutierrez, Jose María Ruiz-Moreno, Amandio Rocha-Sousa, Yashin Ramkissoon, Steven Harsum, Robert E. MacLaren, David Charteris, Jan van Meurs, Rogelio González-Sarmiento & Jose Carlos Pastor. (2013) The p53 Codon 72 Polymorphism (rs1042522) Is Associated with Proliferative Vitreoretinopathy. Ophthalmology 120:3, pages 623-628.
Crossref
Hege O. Ohnstad, Russell Castro, Jinchang Sun, Karen-Marie Heintz, Lyubomir T. Vassilev, Bodil Bjerkehagen, Stine H. Kresse, Leonardo A. Meza-Zepeda & Ola Myklebost. (2013) Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma . Cancer 119:5, pages 1013-1022.
Crossref
Kinjal R. Patel, Bhairavi N. Vajaria, Rasheedunnisa Begum, Franky D. Shah, Jayendra B. Patel, Shilin N. Shukla & Prabhudas S. Patel. (2013) Association between p53 Gene Variants and Oral Cancer Susceptibility in Population from Gujarat, West India. Asian Pacific Journal of Cancer Prevention 14:2, pages 1093-1100.
Crossref
Geo Francis, U Dileep Kumar, KR Nalinakumari, K Jayasree & S Kannan. (2013) Accumulation of inactive p53 protein in oral squamous cell carcinoma: stabilization by protein interaction. European Journal of Oral Sciences 121:1, pages 21-28.
Crossref
Anup R. TilakSachin KumarMohan C. PantNeeraj MathurAshwani Kumar. (2013) Polymorphism Arg72Pro of p53 Confers Susceptibility to Squamous Cell Carcinoma of Lungs in a North Indian Population . DNA and Cell Biology 32:2, pages 66-72.
Crossref
Chunlan Zhou, Qian Wang, Menghuan Zeng, Liping Cheng & Xiaoyun Xie. (2013) The Expressions of P53, MDM2 in Trophoblasts of Spontaneous Abortion Mouse Model and the Relevant Researches. Engineering 05:10, pages 371-375.
Crossref
Pallavi SinghalShowket HussainNisha ThakurSwaraj BatraSudha SalhanSuresh BhambaniMausumi Bharadwaj. (2013) Association of MDM2 and p53 Polymorphisms with the Advancement of Cervical Carcinoma . DNA and Cell Biology 32:1, pages 19-27.
Crossref
Emina J. Malisic, Radmila N. Jankovic, Ksenija V. Jakovljevic & Sinisa S. Radulovic. (2013) Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women. European Journal of Obstetrics & Gynecology and Reproductive Biology 166:1, pages 90-93.
Crossref
Angeles Almeida. (2012) Genetic determinants of neuronal vulnerability to apoptosis. Cellular and Molecular Life Sciences 70:1, pages 71-88.
Crossref
Lukasz F. Grochola, Jorge Zeron-Medina, Emmanouela Repapi, Alexander E. Finlayson, Ying Cai, Gurinder Singh Atwal & Gareth L. Bond. 2013. p53 in the Clinics. p53 in the Clinics 25 46 .
E. Burroni, S. Bisanzi, C. Sani, D. Puliti & F. Carozzi. (2013) Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix. Journal of Medical Virology 85:1, pages 83-90.
Crossref
Tanmayi P. Mankame & Mark W. Lingen. (2012) The RB Tumor Suppressor Positively Regulates Transcription of the Anti-angiogenic Protein NOL7. Neoplasia 14:12, pages 1213-IN38.
Crossref
Steven Habbous, Vincent Pang, Lawson Eng, Wei Xu, Goldie Kurtz, Fei-Fei Liu, Helen Mackay, Eitan Amir & Geoffrey Liu. (2012) p53 Arg72Pro Polymorphism, HPV Status and Initiation, Progression, and Development of Cervical Cancer: A Systematic Review and Meta-Analysis . Clinical Cancer Research 18:23, pages 6407-6415.
Crossref
H. Akbaş, K. Yalcin, H. Isi, S. Tekes, A.E. Atay, Z. Akkus & T. Budak. (2012) Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B. Brazilian Journal of Medical and Biological Research 45:11, pages 1011-1016.
Crossref
Delphine Borchiellini, Marie-Christine Etienne-Grimaldi, Juliette Thariat & Gérard Milano. (2012) The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes. Cancer Treatment Reviews 38:6, pages 737-759.
Crossref
Guangping JingKewen LvXiaohui Jiao. (2012) The p53 Codon 72 Polymorphism and the Risk of Oral Cancer in a Chinese Han Population . Genetic Testing and Molecular Biomarkers 16:9, pages 1149-1152.
Crossref
Joanna Szkandera, Gudrun Absenger, Nadia Dandachi, Peter Regitnig, Sigurd Lax, Michael Stotz, Hellmut Samonigg, Wilfried Renner & Armin Gerger. (2012) Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Molecular Genetics and Genomics 287:9, pages 755-764.
Crossref
Shaohua Gu, Qihan Wu, Xueying Zhao, Wenting Wu, Zhiqiang Gao, Xiaoming Tan, Ji Qian, Hongyan Chen, Yi Xie, Li Jin, Baohui Han & Daru Lu. (2012) Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy . Cancer Science 103:8, pages 1451-1459.
Crossref
Bassam Lajin, Amal Alachkar & Amir Alhaj Sakur. (2012) A quadruplex tetra-primer ARMS–PCR method for the simultaneous detection of TP53 Arg72Pro, IVS3 16bp Del/Ins and IVS6+62A>G, and NQO1 C609T polymorphisms. Gene 504:2, pages 268-273.
Crossref
Arshad A. Pandith, Nighat P. Khan, Nargis Rashid, Niyaz Azad, Inam Zaroo, Adil Hafiz & Mushtaq A. Siddiqi. (2012) Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir. Tumor Biology 33:4, pages 927-933.
Crossref
Kui-Jie Liu, Hai-Zhi Qi, Hong-Liang Yao, San-Lin Lei, Zhen-Dong Lei, Tie-Gang Li & Hua Zhao. (2012) An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk. Molecular Biology Reports 39:8, pages 8265-8275.
Crossref
Kamlesh Guleria, Sarika Sharma, Mridu Manjari, Manjit Singh Uppal, Neeti Rajan Singh & Vasudha Sambyal. (2012) p.R72P, PIN3 Ins16bp Polymorphisms of TP53 and CCR5Δ32 in North Indian Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention 13:7, pages 3305-3311.
Crossref
VINCENT ZIMMER, AKSANA HÖBLINGER, FLORENTINA MIHALACHE, GUNTER ASSMANN, MONICA ACALOVSCHI & FRANK LAMMERT. (2012) Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility. Oncology Letters 4:1, pages 101-106.
Crossref
Ikhlass Hadj Salem, Fatma Kamoun, Nacim Louhichi, Moez Trigui, Chahnez Triki & Faiza Fakhfakh. (2012) Impact of single-nucleotide polymorphisms at the TP53-binding and responsive promoter region of BCL2 gene in modulating the phenotypic variability of LGMD2C patients. Molecular Biology Reports 39:7, pages 7479-7486.
Crossref
Ali A. Alshatwi, Tarique N. Hasan, Gowhar Shafi, Mohammed A. Alsaif, Amal A. Al-Hazzani & Adulaziz A. Alsaif. (2012) A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundamental & Clinical Pharmacology 26:3, pages 438-443.
Crossref
Erwin Reiling, Valeriya Lyssenko, Jolanda MA Boer, Sandra Imholz, W Monique M Verschuren, Bo Isomaa, Tiinamaija Tuomi, Leif Groop & Martijn E T Dollé. (2011) Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time. European Journal of Human Genetics 20:6, pages 696-700.
Crossref
V. Bišof, M. Peričić Salihović, N. Smolej Narančić, T. Škarić-Jurić, J. Jakić-Razumović, B. Janićijević & P. Rudan. (2011) The TP53 gene polymorphisms and survival of sporadic breast cancer patients. Medical Oncology 29:2, pages 472-478.
Crossref
Bin Xiang, Yuan-Yuan Mi, Teng-Fei Li & Peng-Fei Liu. (2012) Updated Meta-analysis of the TP53 Arg72Pro Polymorphism and Gastric Cancer Risk. Asian Pacific Journal of Cancer Prevention 13:5, pages 1787-1791.
Crossref
F. Mashayekhi & S. P. Hadiyan. (2012) A single-nucleotide polymorphism in TP53 may be a genetic risk factor for Iranian patients with idiopathic male infertility. Andrologia 44, pages 560-564.
Crossref
Javier Cotignola, Joanne F. Chou, Pampa Roy, Nandita Mitra, Klaus Busam, Allan C. Halpern & Irene Orlow. (2012) Investigation of the Effect of MDM2 SNP309 and TP53 Arg72Pro Polymorphisms on the Age of Onset of Cutaneous Melanoma. Journal of Investigative Dermatology 132:5, pages 1471-1478.
Crossref
Keith R. Loeb, Maryam M. Asgari, Stephen E. Hawes, Qinghua Feng, Joshua E. Stern, Mingjun Jiang, Zsolt B. Argenyi, Ethel-Michele de Villiers & Nancy B. Kiviat. (2012) Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas. PLoS ONE 7:4, pages e34422.
Crossref
Young-Kwan Lee, Kang-Hoon Lee, Seon-Gyu Kim, Ramzi Melhem, Chang-Suk Moon, Sicong Liu, David G. Greenhalgh & Kiho Cho. (2012) Unique Profile of Ordered Arrangements of Repetitive Elements in the C57BL/6J Mouse Genome Implicating Their Functional Roles. PLoS ONE 7:4, pages e35156.
Crossref
Zhongqiu Wang, Erich M. Sturgis, Wei Guo, Xicheng Song, Fenghua Zhang, Li Xu, Qingyi Wei & Guojun Li. (2012) Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer. PLoS ONE 7:4, pages e35522.
Crossref
Su-Qin Shen, De-Ke Jiang, Guo-Yuan Liu, Fang Chen & Long Yu. (2011) Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk. Molecular Biology Reports 39:4, pages 4683-4690.
Crossref

Displaying 200 of 485 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.